<DOC>
	<DOCNO>NCT02811991</DOCNO>
	<brief_summary>Paracetamol , classical analgesic agent , constitute essential component multi-modal analgesia . This medication generally safe , well tolerated effective within recommended daily dose.The purpose study evaluate efficacy safety Paracetamol Injection adjuvant morphine-based post-operative analgesia , well explore reasonable dosage paracetamol among Chinese population above-mentioned circumstance .</brief_summary>
	<brief_title>A PhaseⅡ/ Ⅲ Seamless Study Evaluate Efficacy Safety Paracetamol Injection Adjuvant Morphine-based Postoperative Analgesia</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Aged 18 70 year inclusively , male female ; Patients schedule open abdominal surgery ( gall bladder , low abdominal investigative surgery ) , gynecologic surgery ( transabdominal hysterectomy ) , orthopedic surgery ( replacement reconstruction knee , hip shoulder joint ) , anticipate need postoperative iv . morphine analgesia≥24h ; 18kg/m2≤BMI≤30 kg/m2 ; Classified ASA risk class I , II accord American Society Anesthesiologists ; Able understand study procedure use pain scale , able operate patient control analgesia ( PCA ) device communicate meaningfully study observer staff ; Patients free contraindication study drug , morphine standardize anesthesia protocol ; Clearly understand procedure study , voluntarily participate provide write consent form . Impaired liver function ( ALT and/or AST &gt; 2 x upper limit normal range , TBIL≥1.5 x upper limit normal range ) ; Impaired renal function ( Serum Creatinine &gt; 176μmoL/L ) , undergoing dialysis within 28 day surgery ; Patients high risk bleeding , include congenital hemorrhagic disease ( Hemophilia ) , Thrombocytopenia ( CBC PLT &lt; 30×109/L ) , Qualitative Plateletdefects ( ITP , DIC , congenital abonormal platelet ) , clinically significant active bleeding ; Abnormal rest ECG , judge eligible entry investigator ; Hypertensive patient achieve satisfactory BP control hypertensive medication ( Sitting SBP≥160mm Hg , and/or DBP≥105mm Hg screen period ) ; Sitting SBP≤90mm Hg screen period ; Diabetic Patients achieve satisfactory blood glucose control ( FBG≥11.1moL/L screen period ) ; Known history bronchial asthma , pulmonary heart disease heart failure ; Participation trial within 30 day ; Pregnant woman woman lactation ; Patients eligible due reason judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>paracetamol</keyword>
	<keyword>post-operative analgesia</keyword>
</DOC>